$2.26
-0.03-1.31%
Last update: Nov 11, 7:57 PM
AC Immune SA (ACIU) Stock Price, Quote, News & History
ACIUNASDAQ
AC Immune reported positive safety and immunogenicity results from Part 1 of its Phase 2 Parkinson's disease trial for ACI-7104.
You can purchase shares of AC Immune (NASDAQ:ACIU) through any online brokerage.
Other companies in AC Immune’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
AC Immune has a consensus price target of $10.00.
The stock price for AC Immune (NASDAQ: ACIU) is $2.26 last updated November 11, 2026 at 7:57 PM EST.
There are no upcoming dividends for AC Immune.
AC Immune does not have any upcoming earnings scheduled.
There is no upcoming split for AC Immune.
AC Immune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover,...
